menu search

Uaw expanding strike to ford, gm plants in chicago, lansing — picket lines at 25k

"Despite our willingness to bargain Ford and GM have refused to make meaningful progress," UAW Presiden...

September 29, 2023, 12:00 pm

Vnq: a solid 'buy' for yield, value, and diversification

VNQ is currently trading at a discounted price due to negativity surrounding REITs, making it an attractive option for value investors. VNQ's top hold...

September 29, 2023, 8:10 am

Abbvie's blood cancer combo therapy fails in late-stage study

AbbVie said on Friday a late-stage study of its experimental combination therapy failed to show meaningful...

September 29, 2023, 8:05 am

Himax: upgrading to 'buy' as worst appears to be behind it

Himax Technologies, Inc. results have been poor, but Q2 likely marked the bottom. The company expects a meanin...

September 27, 2023, 6:10 pm

Jnk: at the center of a credit event

We may be in a credit event, which is negative for SPDR® Bloomberg High Yield Bond ETF. meaningful def...

September 27, 2023, 11:22 am

Eur/usd languishes near its lowest level since march, trades just above mid-1.0500s

EUR/USD struggles to gain any meaningful traction and remains depressed near a multi-month low. The Fed...

September 27, 2023, 3:14 am

Usd/jpy oscillates in a range around 149.00 mark, just below the ytd peak set on tuesday

The USD/JPY pair struggles to gain any meaningful traction on Wednesday and oscillates in a narrow trad...

September 27, 2023, 1:44 am

Micron earnings: investors will be focused on hbm upside potential

Micron's new HBM technology could be a big earner, with improvements in performance, capacity, and power efficiency. MU expects "...

September 26, 2023, 5:33 am

Revolution medicines: a big pipeline in need of big data

Revolution Medicines, Inc. has a diversified pipeline of drugs but is still searching for its flagship project, making it a high-risk investment. The ...

September 25, 2023, 3:24 pm

Novartis (nvs) lutathera meets primary goal in phase iii study

Novartis' (NVS) radioligand therapy Lutathera reports statistically significant and clinically meaningful...

September 25, 2023, 1:32 pm

Usd/mxn price analysis: manages to hold above 100-day sma, bias seems tilted in favour of bulls

The USD/MXN pair manages to defend the 100-day Simple Moving Average (SMA) support through the Asian session on Monday, albeit struggles to gain any <...

September 25, 2023, 3:44 am

1 reason apple stock is a screaming buy, and 1 reason to avoid it like the plague

This FAANG stock has crushed the market over the past five years, but it's down meaningfully since the ...

September 24, 2023, 6:40 am

Morphic to present positive emerald-1 phase 2a data for morf-057 in patients with moderate to severe ulcerative colitis in abstract for uegw 2023

-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvem...

September 22, 2023, 9:30 pm

Morphic to present positive emerald-1 phase 2a data for morf-057 in patients with moderate to severe ulcerative colitis in abstract for uegw 2023

-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvem...

September 22, 2023, 5:30 pm

Igd: time to divest this financials heavy equity cef

Voya Global Equity Dividend and Premium Opportunity Fund is an equity closed-end fund with a 9.6% dividend yield. The fund has failed to produce ...

September 22, 2023, 4:18 pm

Boeing stock lacks a meaningful upside from here: cfra research

Don't hold your breath for a swift recovery in shares of Boeing Co (NYSE: BA) that have lost more than 15% in under two months, says a CFRA Research a...

September 22, 2023, 3:14 pm

Find opportunities for your portfolio with high dividend etf fdvv

Looking to potentially add some current income to your portfolio? With the U.S. economy facing growing headwinds, current income via dividends specifi...

September 22, 2023, 9:13 am

Astrazeneca breast cancer drug gives drugs giant £5bn boost

AstraZeneca PLC (LSE:AZN)'s share price surged by 2.6%, adding nearly £5 billion to the company's market value, following the announcement of encoura...

September 22, 2023, 7:33 am

Astrazeneca signals strong results from breast cancer drug trial

AstraZeneca PLC (LSE:AZN) has hailed strong results from an ongoing trial on the effects of drug datopotamab deruxtecan in breast cancer patients. Acc...

September 22, 2023, 2:54 am

Unlocking potential: 3 retail stocks poised for growth

This article provides short summaries of the three companies that we believe have meaningful upside cat...

September 21, 2023, 4:15 pm


Search within

Pages Search Results: